[go: up one dir, main page]

HK1248110A1 - Plx-8394 or plx-7904 for use in the treatment of braf-v600-related diseases - Google Patents

Plx-8394 or plx-7904 for use in the treatment of braf-v600-related diseases Download PDF

Info

Publication number
HK1248110A1
HK1248110A1 HK18107612.3A HK18107612A HK1248110A1 HK 1248110 A1 HK1248110 A1 HK 1248110A1 HK 18107612 A HK18107612 A HK 18107612A HK 1248110 A1 HK1248110 A1 HK 1248110A1
Authority
HK
Hong Kong
Prior art keywords
plx
braf
treatment
related diseases
diseases
Prior art date
Application number
HK18107612.3A
Other languages
Chinese (zh)
Inventor
Prabha N. Ibrahim
Chao Zhang
Wayne Spevak
Jiazhong Zhang
Guoxian Wu
Jack Lin
Hanna Cho
Marika Nespi
Songyuan Shi
Todd Ewing
Ying Zhang
Gideon Bollag
Original Assignee
Plexxikon, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Plexxikon, Inc. filed Critical Plexxikon, Inc.
Publication of HK1248110A1 publication Critical patent/HK1248110A1/en

Links

HK18107612.3A 2015-05-22 2016-05-20 Plx-8394 or plx-7904 for use in the treatment of braf-v600-related diseases HK1248110A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US62/165,813 2015-05-22

Publications (1)

Publication Number Publication Date
HK1248110A1 true HK1248110A1 (en) 2018-10-12

Family

ID=

Similar Documents

Publication Publication Date Title
GB201614522D0 (en) Use of cannabinoids in the treatment of multiple myeloma
EP3177732A4 (en) Compositions and methods for the treatment of ophthalmic diseases and conditions
EP3122878A4 (en) Mrna therapy for the treatment of ocular diseases
EP3256218A4 (en) Kdm1a inhibitors for the treatment of disease
EP3096617A4 (en) Compositions and methods for treating ocular diseases
EP3182989A4 (en) Methods and compositions for the prevention and treatment of disease
EP3268007A4 (en) Compositions and therapeutic methods for the treatment of complement-associated diseases
EP3188721A4 (en) Human therapeutic agents
EP3148526A4 (en) Use of eribulin in the treatment of cancer
PL3277280T3 (en) Isomyosmine for use in the treatment of autoimmune diseases
EP3218481A4 (en) Biomarkers useful in the treatment of subjects having diseases of the eye
EP3185910A4 (en) Methods and compositions for the treatment of cancer
EP3137907A4 (en) Methods and compositions for the diagnosis and treatment of kawasaki disease
EP3302530A4 (en) Cdh26 based therapeutic agents and their use
EP3119387A4 (en) Compositions for the treatment of dermatological diseases and disorders
EP3148556A4 (en) Skin treatment formulations
IL246855A0 (en) Agents for use in the treatment of retinal inflammation
EP3096775A4 (en) Socs mimetics for the treatment of diseases
EP3154637A4 (en) Treatment of virus-based diseases of the skin
EP3156054A4 (en) Medicine for preventing and/or treating stress-induced diseases
EP3107534A4 (en) Compositions and methods for the treatment of neurodegenerative diseases
EP3283457A4 (en) Compounds and methods for the treatment of neurodegenerative diseases
EP3208262A4 (en) Compounds derived from 3-alkylamino-1h-indole acrylate, and the use thereof in the treatment of neurodegenerative diseases
EP3277726A4 (en) Pain treatment
EP3145525A4 (en) Use of microperoxidases for the treatment of carboxyhemoglobinemia